Eli Lilly initiates phase III trial of LY-CoV555 for prevention of COVID-19 at long-term care facilities in partnership with NIAID.
Why sign up with Medthority?
Develop your knowledge with our disease and condition focused Learning Zones
Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines
Personalised dashboard providing updates and recommendations for content within your areas of interest